Broadening the field of opportunity for medicinal chemists. Official journal of the European Federation for Medicinal Chemistry
Impact Factor 2.722 12 Issues per Year
Review Article

Development of second generation epigenetic agents

Philip Jones*a  
Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Institute for Applied Cancer Sciences, MD Anderson Cancer Center, 1901 East Road, Room 4SCR6.1037, Houston, USA
E-mail: pjones3@mdanderson.org ;
Tel: +1 713 792 6371
Med. Chem. Commun., 2012,3, 135-161

DOI: 10.1039/C1MD00199J
Received 01 Aug 2011, Accepted 17 Sep 2011
First published online 26 Oct 2011

This article is part of themed collection: MedChemComm 2012 review articles and Epigenetics
| | | | | | More
Please wait while Download options loads
Download Citation